FogPharma
Steve MacDonald has extensive experience in finance and accounting, holding roles such as VP of Finance, Corporate Controller at FogPharma and Zenas BioPharma. Steve also served as VP of Finance/Accounting, Treasurer at Eloxx Pharmaceuticals and held various financial reporting positions at TESARO, Inc. and PricewaterhouseCoopers. Steve'sexpertise includes managing headcount reductions, overseeing accounting and finance functions, and leading financial reporting teams.
Steve MacDonald obtained their BA in Sociology from Williams College. Steve then pursued an MBA in Accounting from Suffolk University - Sawyer Business School. In 2005, they became a Certified Public Accountant (CPA) in the Commonwealth of Massachusetts.
FogPharma
1 followers
FogPharma is dedicated to the creation of a new class of medicines that target human disease drivers currently considered “undruggable.” The company’s cell-penetrating miniproteins (CPMPs) combine the targeting power of protein therapeutics with the cell-penetrating ability of small molecules. This unique combination of targeting features enables CPMP’s to access and engage proteins that have long been known to play a major role in causing serious human diseases, but have been frustratingly beyond the reach of therapeutic intervention.